KLF15
Basic information
Region (hg38): 3:126342635-126357408
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLF15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 1 | 0 |
Variants in KLF15
This is a list of pathogenic ClinVar variants found in the KLF15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-126343740-C-A | not specified | Uncertain significance (Feb 28, 2024) | ||
3-126343741-G-T | not specified | Uncertain significance (Jun 30, 2022) | ||
3-126343750-G-A | not specified | Uncertain significance (May 26, 2022) | ||
3-126343784-C-A | not specified | Uncertain significance (May 26, 2022) | ||
3-126343791-A-C | not specified | Uncertain significance (Jun 13, 2024) | ||
3-126351869-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
3-126351893-G-A | not specified | Uncertain significance (Nov 22, 2022) | ||
3-126351958-T-C | not specified | Uncertain significance (Jan 24, 2023) | ||
3-126351971-T-C | not specified | Uncertain significance (Mar 24, 2023) | ||
3-126351999-C-A | not specified | Uncertain significance (Feb 14, 2023) | ||
3-126352009-A-G | not specified | Uncertain significance (Mar 29, 2022) | ||
3-126352136-C-T | not specified | Uncertain significance (Mar 21, 2022) | ||
3-126352198-G-T | not specified | Uncertain significance (Dec 12, 2023) | ||
3-126352199-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
3-126352211-A-G | not specified | Uncertain significance (Jun 03, 2022) | ||
3-126352256-T-A | not specified | Uncertain significance (Jan 04, 2024) | ||
3-126352265-A-C | not specified | Uncertain significance (Sep 20, 2022) | ||
3-126352277-G-A | not specified | Uncertain significance (Jan 17, 2023) | ||
3-126352333-C-G | not specified | Uncertain significance (Apr 10, 2023) | ||
3-126352351-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
3-126352352-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
3-126352520-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
3-126352526-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
3-126352553-C-T | not specified | Uncertain significance (Dec 14, 2023) | ||
3-126352732-T-C | not specified | Uncertain significance (Mar 07, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KLF15 | protein_coding | protein_coding | ENST00000296233 | 2 | 14808 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.488 | 0.507 | 125536 | 0 | 5 | 125541 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.985 | 202 | 245 | 0.823 | 0.0000157 | 2666 |
Missense in Polyphen | 51 | 86.406 | 0.59024 | 973 | ||
Synonymous | 0.151 | 104 | 106 | 0.981 | 0.00000735 | 884 |
Loss of Function | 2.39 | 2 | 10.3 | 0.195 | 5.14e-7 | 130 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000101 | 0.0000995 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000380 | 0.0000353 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator that binds to the GA element of the CLCNKA promoter. Binds to the KCNIP2 promoter and regulates KCNIP2 circadian expression in the heart (By similarity). Is a repressor of CTGF expression, involved in the control of cardiac fibrosis. It is also involved in the control of cardiac hypertrophy acting through the inhibition of MEF2A and GATA4 (By similarity). Involved in podocyte differentiation (By similarity). Inhibits MYOCD activity. Is a negative regulator of TP53 acetylation. Inhibits NF-kappa-B activation through repression of EP300-dependent RELA acetylation. {ECO:0000250, ECO:0000269|PubMed:18586263, ECO:0000269|PubMed:20375365, ECO:0000269|PubMed:20566642, ECO:0000269|PubMed:23999430}.;
- Disease
- DISEASE: Note=KLF15 deficiency results in loss of rhythmic QT variation and abnormal heart repolarization (PubMed:22367544). It may play a role in susceptibility to ventricular arrhythmias (PubMed:22367544), and development of pathological cardiac hypertrophy leading to heart failure (PubMed:20375365). {ECO:0000269|PubMed:20375365, ECO:0000269|PubMed:22367544}.;
- Pathway
- White fat cell differentiation;Adipogenesis;BMAL1-CLOCK,NPAS2 activates circadian gene expression;White fat cell differentiation;Transcriptional cascade regulating adipogenesis;Circadian Clock;BMAL1:CLOCK,NPAS2 activates circadian gene expression
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.200
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.62
Haploinsufficiency Scores
- pHI
- 0.382
- hipred
- Y
- hipred_score
- 0.559
- ghis
- 0.601
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.826
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Klf15
- Phenotype
- liver/biliary system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; renal/urinary system phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- cellular glucose homeostasis;regulation of transcription by RNA polymerase II;glial cell differentiation;cardiac muscle hypertrophy in response to stress;response to insulin;positive regulation of transcription by RNA polymerase II;positive regulation of glucose import;glomerular visceral epithelial cell differentiation;negative regulation of peptidyl-lysine acetylation
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding;transcription regulatory region DNA binding;metal ion binding